Mereo BioPharma Group plc (AIM:MPH)
London
· Delayed Price · Currency is GBP · Price in GBX 26.50
-0.50 (-1.85%)
At close: Dec 17, 2020
Mereo BioPharma Group Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 40.99 | 69.8 | 57.42 | 68.18 | 126.91 | Upgrade
|
| Short-Term Investments | - | - | - | - | 0.77 | Upgrade
|
| Cash & Short-Term Investments | 40.99 | 69.8 | 57.42 | 68.18 | 127.68 | Upgrade
|
| Cash Growth | -41.27% | 21.56% | -15.78% | -46.60% | 298.48% | Upgrade
|
| Other Receivables | 1.98 | 3.25 | 3.73 | 2.31 | 2.46 | Upgrade
|
| Receivables | 1.98 | 3.25 | 3.73 | 2.31 | 2.46 | Upgrade
|
| Prepaid Expenses | 0.38 | 0.27 | 0.97 | 3.78 | 3.79 | Upgrade
|
| Other Current Assets | 1.66 | 1.44 | 1.64 | 0.92 | 0.55 | Upgrade
|
| Total Current Assets | 45.02 | 74.76 | 63.76 | 75.2 | 134.49 | Upgrade
|
| Property, Plant & Equipment | 0.38 | 0.98 | 1.65 | 2.22 | 3.43 | Upgrade
|
| Other Intangible Assets | 0.52 | 0.64 | 1.09 | - | 33.26 | Upgrade
|
| Total Assets | 45.92 | 76.39 | 66.5 | 77.41 | 171.18 | Upgrade
|
| Accounts Payable | 1.43 | 2.68 | 2.35 | 3.49 | 3.09 | Upgrade
|
| Accrued Expenses | 2.35 | 4.57 | 5.75 | 5.64 | 5.44 | Upgrade
|
| Current Portion of Long-Term Debt | - | 5.54 | - | 13.33 | - | Upgrade
|
| Current Portion of Leases | 0.2 | 0.71 | 0.65 | 0.56 | 0.84 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 2.06 | Upgrade
|
| Other Current Liabilities | 0.33 | 0.36 | 0.74 | 1.36 | 5.55 | Upgrade
|
| Total Current Liabilities | 4.3 | 13.85 | 9.49 | 24.38 | 16.98 | Upgrade
|
| Long-Term Debt | - | - | 4.39 | - | 19.48 | Upgrade
|
| Long-Term Leases | - | 0.19 | 0.91 | 1.48 | 2.38 | Upgrade
|
| Other Long-Term Liabilities | 0.7 | 1.39 | 1.18 | 0.16 | 13.18 | Upgrade
|
| Total Liabilities | 5 | 15.42 | 15.96 | 26.01 | 52.02 | Upgrade
|
| Common Stock | 3.14 | 3.06 | 2.78 | 2.48 | 2.38 | Upgrade
|
| Additional Paid-In Capital | 549.62 | 539.64 | 486.11 | 476.52 | 335.08 | Upgrade
|
| Retained Earnings | -501.02 | -462.88 | -419.63 | -404.58 | -402.11 | Upgrade
|
| Treasury Stock | - | - | -1.23 | -1.34 | - | Upgrade
|
| Comprehensive Income & Other | -10.82 | -18.85 | -17.49 | -21.69 | 183.82 | Upgrade
|
| Shareholders' Equity | 40.92 | 60.97 | 50.54 | 51.4 | 119.16 | Upgrade
|
| Total Liabilities & Equity | 45.92 | 76.39 | 66.5 | 77.41 | 171.18 | Upgrade
|
| Total Debt | 0.2 | 6.43 | 5.95 | 15.37 | 22.69 | Upgrade
|
| Net Cash (Debt) | 40.79 | 63.37 | 51.47 | 52.81 | 104.99 | Upgrade
|
| Net Cash Growth | -35.63% | 23.13% | -2.54% | -49.70% | 1289.80% | Upgrade
|
| Net Cash Per Share | 0.26 | 0.43 | 0.39 | 0.44 | 0.95 | Upgrade
|
| Filing Date Shares Outstanding | 159.62 | 159 | 140.01 | 124.74 | 116.73 | Upgrade
|
| Total Common Shares Outstanding | 159.13 | 155.15 | 140 | 124.74 | 116.73 | Upgrade
|
| Working Capital | 40.72 | 60.92 | 54.27 | 50.82 | 117.51 | Upgrade
|
| Book Value Per Share | 0.26 | 0.39 | 0.36 | 0.41 | 1.02 | Upgrade
|
| Tangible Book Value | 40.4 | 60.33 | 49.45 | 51.4 | 85.9 | Upgrade
|
| Tangible Book Value Per Share | 0.25 | 0.39 | 0.35 | 0.41 | 0.74 | Upgrade
|
| Machinery | 0.46 | 0.49 | 0.5 | 0.61 | 0.48 | Upgrade
|
| Leasehold Improvements | 0.76 | 0.71 | 0.71 | 0.68 | 0.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.